2009
DOI: 10.1039/b820121h
|View full text |Cite
|
Sign up to set email alerts
|

Interfaces for capillary LC with ICPMS detection: A comparison of nebulizers/spray chamber configurations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 29 publications
(44 reference statements)
1
17
0
Order By: Relevance
“…These results also suggest that a larger oligonucleotide component (i.e., more phosphorus per oligonucleotide component) would be advantageous for ICPMS detection when using the HFIP/TEA mobile phase conditions. The LOD values obtained here (≤ μmol concentration) are comparable to values previously reported for cross-link or heteroconjugate characterization by LC-ESI-MS [16-21], and additional investigation of alternative nebulization sources may improve these LOD values further [32]. …”
Section: Resultssupporting
confidence: 86%
See 2 more Smart Citations
“…These results also suggest that a larger oligonucleotide component (i.e., more phosphorus per oligonucleotide component) would be advantageous for ICPMS detection when using the HFIP/TEA mobile phase conditions. The LOD values obtained here (≤ μmol concentration) are comparable to values previously reported for cross-link or heteroconjugate characterization by LC-ESI-MS [16-21], and additional investigation of alternative nebulization sources may improve these LOD values further [32]. …”
Section: Resultssupporting
confidence: 86%
“…Because the separation of biomolecules, such as peptides and oligonucleotides, using RP-HPLC typically requires high concentrations of organic solvent or buffer to elute the sample from the column, care must be taken to reduce the overall volume of LC eluent introduced into the ICP source. Thus, we first examined both peptide-based RP-HPLC conditions, where TFA is present in the mobile phase, and conventional oligonucleotide ion-pairing RP-HPLC conditions, where HFIP and TEA are the major components of the mobile phase, using cap-LC to ensure that the mobile phase conditions amenable to ICP-MS [31, 32] would adequately separate the biomolecules of interest. The acidic mobile phases and solution conditions investigated have been utilized previously with heteroconjugates, such as that used here as a model system, and were not found to affect the integrity of the heteroconjugate [13, 21, 25, 26].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Aside from these problems that are mainly related to the plasma solvent load, coupling HPLC-based methods with ICP-MS detection is a relatively straightforward task, as the eluent flow of the separation module is within the sample uptake range of these systems, or can at least be matched by either selecting the flow rate (by selecting a standard, micro-, or nanobore HPLC system) [35] or adapting the nebulizing system (standard-, micro-, or nanoflow nebulizer) [36].…”
Section: Hplc/icp-msmentioning
confidence: 99%
“…coupling. Particular attention must be paid both to the quality of the aerosol produced through the nebulizer/spray chamber [50] and to the contribution of the whole interface to peak band broadening [3,44,45,[51][52][53], both features being able to significantly affect the sensitivity. A well-documented summary of SIS devices was reported by Leclerq and al.…”
Section: Lc-icp-ms Interfacementioning
confidence: 99%